FDA Investigator Bijoy Panicker

Bijoy Panicker has inspections in 13 countries as of 11 Jan 2024. Bijoy Panicker has collaborated with a combinined 6646 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
72
Last Inspection Date:
11 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Greece, China, Japan, Taiwan, Ireland, Switzerland, Germany, Viet Nam, France, Norway, Italy
Co-Investigator(s):
Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Althea A Williams, Amatul H Marium, Anastasia I Offordile, Anastasia M Shields, Andrew F Cohen, Anita R Michael, Anthony Kovalenko, Arduino Frankovic, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Avital A Shimanovich, Azza Talaat, Barbara A Gullick, Bichsa T Tran, Bijoy Panicher, Binh T Nguyen, Blondell W Johnson, Bonita S Chester, Brandy N Lepage, Brian J Ryan, Brooke K Higgins, Carla A Norris, Carla J Lundi, Carrie E Jolly, CDR Donald Ertel, Chaltu N Wakijra, Charanjeet Jassal, Charisse K Green, Charles I Ann, Cheryl A Clausen, Chiang Syin, PhD, Christian Parra, Christina K Theodorou, Christine A Falabella, Christine M Rivera, Claire M Minden, Cody D Rickman, Concepcion Cruz, Jr, Constance Y Fears, Constantin Y Philopoulos, Cynthia A Palmer, Cynthia Jim, CSO, Daniel J Roberts, Daniel L Zheng, David A Oluwo, David R Delucia, Dawn E Barkans, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald L Lech, Dongping Dai, PhD, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Dominick Roselle, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Eileen A Liu, Emest F Bizjak, Emmanuel J Ramos, Eric L Dong, BS, Erik W Koester, Erika E Englund, PhD, Erin L Nagel, Erk W Koester, Farhana Khan, Feiyan Jin, Felix Maldonado, Francis A Guidry, Frank Verni, Gam S Zamil, Ganesh N Joshi, Gary J Lader, Gary J Lehr, Gary T Greco, Gayle S Lawson, George J Flynn, George Pyramides, Gray, Guerlain Ulysse, Hala L Selby, Hala Lj Whetstone, Harry J Brewer, Hector J Colon Torres, Helen B Ricalde, Helen Verdel, Iram R Hassan, PhD, Irina Gaberman, Ivan E Reyes, Ivy E Sweeney, Jacqueline Mdiaz Albertini, James A Liubicich, James C Maclaughlin, James D Bridges, James I Giefer, James M Mason, James M Simpson, Jay T Wong, Jazmine N Brown, Jazmine N Still, Jeffrey A Sommers, Jennifer A Bazergui, Jeremy W Rotton, Joel D Martinez, Jogy George, John A Gonzalez, John A Podsadowski, John D White, John F Cipollo, Johnna L Bleem, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose O Hernandez, Jose R Hernandez, Joseph J Vannelli, Joseph Maselli, Joseph W Matthews, Josh Renzon Ramilo, Joshua P Wireman, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Juliana Falla, Juliana M Badalucco, Julianne C Mccullough, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Briggs, Karen C Daugherty, Karen L Kosar, Karishma G Gopaul, Karl Auguste, Katherine Szestypalow, Kathleen M Jordan, Kellia N Hicks, Kelly R Lewis, Kendra L Brooks, Kenneth Gordon, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Ko U Min, Kristen Nickens, PhD, Kristina L Conroy, Kwong P Lee, Lakshmi Narasimhan, PhD, Lance M De Souza, MBA, Larry K Austin, Larry K Hampton, Lata C Mathew, PhD, Laura Fontan, MS, Laurie Nelson, Lawrence Harmon, Jr, Lawrence W Farina, LCDR Chad N Thompson, LCDR Debra Emerson, Leslie Arivera Rosado, PhD, Liming Zhang, Linda F Murphy, Linda M Hoover, Linda M Sacco, Linda Thai, Lindsey Brown, PhD, Lisa M Bellows, Lisa Mathew, Lori S Lawless, LT Daveta L Bailey, Luis A Dasta, Madushini Dharmasena, PhD, Maida Henesian (NMI), Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Margaret E Sarles, Margaret M Doherty, Margaret M Sands, Maria C Shih, Maria Gutierrez Lugo, PhD, Marie Bbuen Bigornia, Marisa R Eschmann, Mark R Mcclain, Massod Rahimi, PhD, Matthew A Spataro, Matthew B Casale, Matthew D Schnittker, Matthew M Henciak, Meena Bansal Gupta, PhD, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Meredith P Soehl, Investigator, Merry Christie, PhD, Michael A Charles, Michael L Casner, Michael L Chasey, Michael Levin, Michael R Dominick, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michael W Burd, Michele Gottshall, Michele L Obert, Miguel A Martinez, Mihaly S Ligmond, Milan S Mcgorty, Mindy M Chou, Monica Cburgos Garcia, Monika Borkowska, Mra Davism, Mra Mcculloughj, Mra Narulaa, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy L Rolli, Nancy M Espinal, Nancy T Waites, Nazmul Hassan, Neal L Adams, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Omadevi Somai, Investigator, Omotunde O Osunsanmi, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula A Trost, Perez, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Prabhu P Raju, Qin Xu, Rachael A Moliver, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Rajiv R Srivastava, Ramon A Hernandez, Randy L Self, Raymond D Kent, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Rita K Kabaso, Rober C Horan, PhD, Robert C Steyert, Robert H Wittorf, Robert J Martin, Rochelle K Kimmel, Rory K Geyer, Rose M Ashley, Ross J Grigsby, Ruben C Quintana, S Lori Brown, PhD MPH, Sachinkumar V Patel, Saleem A Akhtar, Sam Pepe, Samina S Khan, Samuel T Walker, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah A Meehan, Sarah A Wangseng, Sarah Kennett, PhD, Satheesh Thomas, Sayyem H Akbar, Scott E Norris, Sena G Dissmeyer, Shari L Kahn, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Sonia E Ortiz, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, State Agency, Stephanie A Slater, MS, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Steven A Gonzales, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susan M Joseph, Susan W Ting, Susant Hadman, Syeda N Mahazabin, Tajah L Blackburn, Tamara Brey, Tanya R Syffrard, Tara K Carmody, Teresa I Navas, Terry Bridgewater, Thao T Kwan, Theresa Kirkham (NMI), Thomas E Friel, Thomas J Arista, Thomas J Mooney, Thomas S Arista, Thomas W Nojek, Tiffani D Wilson, Tina S Roecklein, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Tracy M Portelli, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Uduak M Inokon, Valerie A Potopsingh, Viviana Matta, Vivin George, Vlada Matusovsky, Walden H Lee, Walter L Fava, Wanda Y Honeyblue, Wayne E Seifert, Wendy G Tan, PhD, William J Leonard, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Yumi J Hiramine, Yuyan Liang, Yvesna C Blaise, Yvins Dezan, Yvonne M Santiago, Zachary A Bogorad, Zhaoyang Meng, Zhong Li, PhD, Zhongren Wu

Bijoy Panicker's Documents

Publish Date Document Type Title
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
January, 2023 FDA 483 Keshava Organics Private Limited - Form 483, 2023-01-13
March, 2021 FDA 483 Evaric Pharmaceuticals Inc - Form 483, 2021-03-01
March, 2018 EIR ScieGen Pharmaceuticals, INC. - EIR, 2018-03-14
May, 2018 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2018-05-25
May, 2018 EIR InvaGen Pharmaceuticals, Inc - EIR, 2018-05-25
October, 2020 EIR Ascent Pharmaceuticals Inc - EIR, 2020-10-13
August, 2020 FDA 483 Savings Distributors LLC - Form 483, 2020-08-27
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
February, 2022 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2022-02-11
November, 2018 FDA 483 Response Amneal Pharmaceuticals, LLC - Form 483R, 2018-12-18
November, 2018 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2018-11-28
September, 2023 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2023-09-19
November, 2016 EIR Viarex Wholesale Inc. - EIR, 2016-11-29
January, 2023 FDA 483 Anicare Pharmaceuticals Pvt. Ltd. - Form 483, 2023-01-20
September, 2016 FDA 483 T&L Creative Salads, Inc. - Form 483, 2016-09-21
February, 2022 FDA 483 Response Altaire Pharmaceuticals Inc. - Form 483R, 2022-03-10
August, 2021 FDA 483 The Skin Atelier, Inc. - Form 483, 2021-08-25
June, 2018 FDA 483 Ultra Seal Corporation - Form 483, 2018-06-29
February, 2018 FDA 483 Dsm Nutritional Products GmbH - Form 483, 2018-02-02
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
July, 2021 FDA 483 Response LNK International, Inc. - Form 483R, 2021-07-23
March, 2022 FDA 483 American Cleaning Solutions - Form 483, 2022-03-28
October, 2020 FDA 483 Ascent Pharmaceuticals Inc - Form 483, 2020-10-13
April, 2022 FDA 483 Contract Pharmacal Corp. - Form 483, 2022-04-14
February, 2019 EIR Steriscience Specialties Private Limited - EIR, 2019-02-14
April, 2019 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2019-04-19
March, 2018 EIR ScieGen Pharmaceuticals, INC. - EIR, 2018-03-16
May, 2017 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2017-05-10
November, 2022 EIR Bora Pharmaceuticals Ophthalmic Inc. Taoyuan plant - EIR, 2022-11-04
February, 2017 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2017-02-01
March, 2023 FDA 483 Saptalis Pharmaceuticals LLC - Form 483, 2023-03-17
November, 2022 FDA 483 Bora Pharmaceuticals Ophthalmic Inc. Taoyuan plant - Form 483, 2022-11-04
February, 2019 FDA 483 Response Steriscience Specialties Private Limited - Form 483R, 2019-03-08
June, 2018 EIR Ultra Seal Corporation - EIR, 2018-06-29
October, 2019 FDA 483 YUNG SHIN PHARM. IND. CO., LTD. - Form 483, 2019-10-22
May, 2021 FDA 483 Apothecus Pharmaceutical Corp. - Form 483, 2021-05-17
July, 2021 FDA 483 LNK International, Inc. - Form 483, 2021-07-01
February, 2018 EIR Dsm Nutritional Products GmbH - EIR, 2018-02-02
July, 2018 FDA 483 Meiji Seika Pharma Co., Ltd. - Form 483, 2018-07-20
July, 2018 FDA 483 Shionogi Pharma Co., Ltd. - Form 483, 2018-07-26
April, 2019 FDA 483 Response Altaire Pharmaceuticals Inc. - Form 483R, 2019-05-10
March, 2017 FDA 483 Glaxo Wellcome Production - Form 483, 2017-03-03
February, 2017 EIR Fresenius Kabi USA, LLC - EIR, 2017-02-01
March, 2022 FDA 483 PHARMATHEN INTERNATIONAL S.A. - Form 483, 2022-03-09
June, 2022 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2022-06-15
August, 2018 FDA 483 KOSE INDUSTRIES K.K. - Form 483, 2018-08-03
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
August, 2019 FDA 483 DR.REDDY'S LABORATORIES LIMITED - Form 483, 2019-08-20
October, 2018 FDA 483 Honour Lab Limited - Form 483, 2018-10-12
October, 2022 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2022-10-06
June, 2017 FDA 483 KVK-TECH, INC. - Form 483, 2017-06-27
October, 2018 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2018-10-19
April, 2018 FDA 483 American Regent, Inc. - Form 483, 2018-04-11
February, 2020 FDA 483 Sionc Pharmaceuticals Private Limited - Form 483, 2020-02-07
October, 2019 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2019-10-22
August, 2022 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2022-08-10
July, 2021 EIR LNK International, Inc. - EIR, 2021-07-01
January, 2024 FDA 483 Chartwell Pharmaceutical Carmel LLC - Form 483, 2024-01-11
October, 2023 FDA 483 Eisai Co., Ltd. - Form 483, 2023-10-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more